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Abstract 
Olive oil is a rich source of polyphenols, in particular the phenolic acids hydroxytyrosol and 
tyrosol, and their conjugated forms, such as oleuropein. The bioactivity of these compounds in 
vivo will depend on the extent of their absorption and metabolism. We have conducted a detailed 
investigation of the absorption, metabolism and microflora-dependent transformation of olive oil 
polyphenols at different sites in the gastrointestinal tract. The results show that conjugated forms 
undergo rapid hydrolysis in acidic gastric conditions, resulting in an increase in the amount of free 
HT and TYR in the small intestine (475% and 325%, respectively at 30min). These phenols were 
demonstrated to be absorbed in both human Caco-2 cells (Papp = 2.18±0.37x10-5 for HT and 
5.11±0.59x10-5 for TYR) and rat segments of the jejunum (Papp = 1.26±0.52x10-5 for HT and 
3.55±0.11x10-5 for TYR) and the ileum (Papp = 1.41±0.99x10-5 for HT and 2.91±0.56x10-5 for 
TYR). Upon uptake into jejunum or ileum, the compounds underwent various biotransformations 
via classic phase I/II metabolism pathways. The major metabolites identified were the O-
methylated derivatives of HT, O-glucuronides of HT and TYR, and a glutathionylated conjugate of 
HT. In contrast, there was no absorption of oleuropein in either small intestinal model.  However 
oleuropein was rapidly degraded by the colonic microflora resulting in the formation of HT. Our 
data indicate that although many of the complex polyphenols present in olive oil (oleuropein and 
secoiridoids derivatives) are not absorbed, these may be degraded in the GI tract to yield 
increased amounts of HT and TYR, which may be absorbed and exert biological effects. 
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Introduction 
Olive oil is the principal fat component of the Mediterranean diet, and its consumption has been 
associated with a lower incidence of coronary heart disease (CHD) and certain cancers [1-4]. Extra 
virgin olive oil contains a variety of simple phenolic compounds, such as hydroxytyrosol (HT), 
tyrosol (TYR), and their secoiridoid derivatives, such as oleuropein (OL) and its aglycone form. 
These compounds, together with other components, such as tocopherols, contribute towards the 
protection of olive oil against auto-oxidation, and have been demonstrated to exert many potentially 
beneficial biological effects both in vitro and in vivo [5-11]. However, the biological properties of 
these compounds in vivo will depend on the extent of their absorption and metabolism. In vivo 
studies have been performed to investigate the bioavailability of olive oil polyphenols by 
measurement of their excretion in urine following administration [12-15]. It has been reported that 
hydroxytyrosol and tyrosol levels in urine increase after olive oil administration, and that these 
compounds were primarily excreted as O-glucuronidated conjugates [15-17]. Hydroxytyrosol may 
also be O-methylated in vivo, and homovanillic acid and homovanillyl alcohol have been measured 
in human and animal studies in plasma and urine after olive oil ingestion [12, 16, 18, 19]. In 
addition, human studies conducted in healthy and ileostomy patients fed with polyphenols have 
show that ingested olive oil phenols were absorbed in healthy and ileostomy subjects, which 
indicates that most, if not all, are absorbed in the small intestine [20]. However, only few data exist 
for the absorption and metabolism of olive oil polyphenols in the small intestine, and there are little 
or no data for their stability in the stomach or their biotransformation in the colon. For example, 
Manna et al. [21] reported that HT is absorbed by passive diffusion in Caco-2 cells but there are no 
data on the specific absorption/metabolism of other olive oil polyphenols in the small intestine.  
 
The aim of this study was to investigate the absorption, subsequent biotransformation and potential 
modification of a range of olive oil polyphenols (including oleuropein and secoiridoid derivatives) in 
the gastrointestinal tract.  In particular we focus on their decomposition in the stomach, their 
absorption and metabolism in the small intestine and their biotransformation by the microflora 
present in the large intestine. Knowledge of the detailed biotransformation of olive oil 
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polyphenols in the gastrointestinal tract will provide important information regarding potential 
bioactive components in vivo. 
 
 
Materials and Methods 
Materials.  
The polyphenolic mixture was obtained by processing extra virgin olive oil by methanol/water 
extraction as previously described by Caruso et al. [17]. The Caco-2 cell line was obtained from 
ECACC (Salisbury, Wiltshire UK). Tyrosol and oleuropein were obtained from Extrasynthase (ZI 
Lyon Nord, Genay, France). Hydroxytyrosol was obtained from Cayman Chemical Company (Ann 
Arbor MI, USA). β-Glucuronidase (type L-II from limpets) was purchased from Sigma (Poole, 
Dorset, UK). Peptone water, yeast extract and bile salts were purchased from Oxoid. Ltd. 
(Basingstoke, UK). HPLC grade acetonitrile and methanol were purchased from Fisher (Hampton, 
NH) and Elgstat UHP double distilled water (18.2 Ω grade) was used throughout the study. HPLC 
columns were purchased from Waters (Watford, Herts, UK). All other reagents used were obtained 
from Sigma. 
 
Incubation of polyphenolic fraction with simulated gastric juice. 
In order to obtain information about the breakdown susceptibility of conjugated forms, polyphenolic 
fraction (1mg/ml) was submitted to acidic hydrolysis under conditions similar to the gastric 
environment (water acidified with HCl to reacha pH=2) and incubated at 37ºC for 30min, 1h, 2h and 
4h. After incubation, samples were analyzed by HPLC detection (see later).  
 
Transport and metabolism experiments in the perfused rat intestinal model. 
Transport and metabolism experiments were conducted using the in vitro intestinal preparation of 
Fisher and Gardner [22, 23] in which the lumen of isolated intestine is perfused with a segmental 
flow (defined as perfusion of buffer interspersed with bubbles of the gas mixture) of bicarbonate 
buffer (pH 7.4) equilibrated with 95% O2:5% CO2 and containing 28 mM glucose. The bicarbonate 
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buffer consisted of HCO3− 25 mM; Na+ 143 mM; Cl− 133.7 mM; K+ 5.9 mM; HPO4− 1.2 mM; Ca2+ 2 
mM and Mg2+ 1.2 mM.  Male Sprague-Dawley rats (230–260 g) were anaesthetized with 
pentobarbital sodium (90 mg/kg, intra-peritoneally) and sections of jejunum (20–30 cm long, 
beginning 10 cm from the ligament of Treitz) or ileum (20–30 cm long, ending 5 cm from the ileo-
caecal junction) were cannulated and the lumen was segmentally perfused with the buffer 
described above. The intestinal sections were then removed from the animal by stripping them from 
the mesentery, and suspended in a chamber containing liquid paraffin at 37°C whilst maintaining 
the segmental flow of buffer. Before transport experiments were started the segments were 
perfused for 40 min in order to flush blood from the vasculature and to allow fluid absorption to 
reach a steady state. Thereafter, hydroxytyrosol (54μM), tyrosol (62,5μM), oleuropein (100μM) and 
polyphenolic fraction (18mg/L) were added to the buffer and perfused through the intestinal 
segment, in a single pass fashion, for up to 80 min. During perfusion, absorbed fluid dropped 
through the paraffin to the base of the chamber and was collected at timed intervals of 20min. 
Samples collected from both the jejunum and the ileum were immediately stored at -20°C until 
analysis. The presence of glucuronide conjugates in the gut samples was established by treatment 
with ß-glucuronidase. Incubation of samples with enzyme (2000 units/ml) was for 120 min at 37°C 
in a 0.1M sodium phosphate buffer, pH 3.8. The 0.1M phosphate buffer effectively inhibits all 
sulphatase activity that the enzyme possesses. A glucuronide of an unknown tyrosol metabolite has 
been characterized and quantified at 280nm with tyrosol as the reference compound. 
 
Cell Culture.  
Sub-cultures of the Caco-2 cells were grown in T-75 culture flasks and passaged with a trypsin-
versene solution. Cells were cultured in DMEM supplemented with 20% FBS, 1% non essential 
amino acids, 2mM L-glutamine, penicillin (100 units/ml), and streptomycin (100 g/ml) at 37°C in 5% 
CO2. 
 
Transport experiments in the human Caco-2 cell culture model.  
For all transcellular transport studies, Caco-2 cells were seeded in 12mm i.d. Transwell inserts 
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(polycarbonate membrane, 0.4μm pore size; Corning Costar Corp.) in 12-well plates at a density of 
5x104 cells/ml. The basolateral (serosal) and apical (mucosal) compartments contained 1.5 and 0.5 
ml of culture medium, respectively. Culture medium was replaced three times a week for 21 days. 
Before the transport experiment media in both chambers was replaced with Hepes-buffered 
medium (HBM; pH 7.4; 5mM Hepes, 154mM NaCl, 4.6mM KCl, 33mM glucose, 5mM NaHCO3, 
1.2mM Na2HPO4). Caco-2 cells in transwells at passage 25 to 40 were used for transport 
experiments at 21 days post seeding. Only inserts with transepithelial electrical resistance (TEER) 
values >300Ω/cm2 were used for transport experiments. Different concentrations of HT, TYR and 
OL (10, 50 and 100μM) and POL (5, 25 and 50 μg/ml) in methanol were added in the apical side 
and upon termination of the 2h incubation at 37°C, samples from both compartments were collected 
for immediate HPLC analysis. 
 
Synthesis of hydroxytyrosol–glutathione conjugate 
Hydroxytyrosol–glutathione conjugate was prepared by a method similar to that previously 
described by Spencer et al [24] for catecholamine conjugates, with some modifications. GSH 
(10mM) and mushroom tyrosinase (2000 units/ml) were incubated in sodium acetate buffer (20 
mM), pH 6.5, at 25°C (total volume of 10ml) before the drop-wise addition of hydroxytyrosol (10mM) 
under constant stirring for 1h. To stop the reaction the sample mixture was acidified with 0.5% HCl 
5M and after centrifugation the supernatant was collected for HPLC analysis. 
 
Colonic microflora fermentation: batch culture. 
The composition of the basal growth medium, per liter, was: peptone (2g), yeast extract (2g), Tween 
80 (2ml), hemin (50mg), vitamin K1 (10µl), L-cysteine HCl (0.5g), bile salts (0.5g), NaCl (0.1g), 
NaHCO3 (2g), K2HPO4 (40mg), KH2PO4 (40mg), MgSO4-7H2O (10mg), CaCl2-6H2O (10mg), 
resazurin (1mg), and distilled water to volume. The medium was dispensed into the fermentation 
vessels and autoclaved at 121ºC for 15 min. Post-autoclaving, the hot medium was purged with 
oxygen-free nitrogen at the rate 15 ml/min. Fecal slurry of 10% (w/v) feces was prepared by 
homogenizing a stool sample with anaerobic phosphate-buffered saline (0.1 M, pH 7.0) in a 
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stomacher. The slurry was sieved to remove particulate material. Fecal donors were aged 20 to 40 
years, had no history of gastrointestinal disease, and had not taken antibiotics in the 6 months prior 
to donation. Samples were processed within 10 min of defecation. The fermentation volume was 
150 ml. Each batch culture (substrate fermentation and control fermentations) consisted of 90% 
basal growth medium and10% fecal slurry. Oleuropein (1mM) was added to the vessel and culture 
pH was maintained at 6.8-7.0 throughout the incubation. Continuous monitoring of pH and 
automatic addition of alkali (0.5M NaOH) and acid (0.5M HCl) was automated by use of an 
Electrolab pH controller. Cultures were incubated at 37ºC by a heated water jacket, continuously 
purged with oxygen-free nitrogen (15 ml/min), and mixed on a magnetic stirrer. The fermenters 
were made of glass and had sampling ports to remove culture medium for analysis through the 
incubations, at time 0, 4h, 8h, 12h, 24h and 48 h. Following sampling from fermentation vessels, the 
suspension was spun for 5 min at 13,000xg. The resultant supernatant was used for HPLC 
analysis. The experiment was carried out in duplicate and using 3 different fecal donors. 
 
HPLC analysis.  
HPLC analysis to measure compound and metabolite concentrations was carried out with a 
Hewlett-Packard 1100 series liquid chromatograph (Hewlett-Packard, Palo Alto, CA) equipped with 
a diode array detector linked to the HP ChemStation Software system. Samples were analyzed by 
reverse-phase HPLC using a Nova-Pak C18 column (4.6 * 250 mm) (Waters Company) with 4μm 
particle size. The temperature of the column was maintained at 30°C. The mobile phases consisted 
of a mixture of aqueous methanol 5% in 0.1% hydrochloric acid 5M (A) and a mixture of aqueous 
acetonitrile 50% in 0.1% hydrochloric acid 5M (B) and were pumped through the column at 0.7 
ml/min. The following gradient system was used (min/% B): 0/5, 5/5, 40/50, 55/100, 59,9/100, 60/5, 
whit 10min post-run for both compound and metabolite detections. The eluent was monitored by 
photodiode array detection at 280nm and spectra of products obtained over the 200^600 nm range. 
Calibration curves of the compounds were constructed using authentic standards (0.1 to 100 M) 
and in each case were found to be linear with correlation coefficients of >0.995. 
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Calculations and Statistics. 
Apparent permeability coefficients (Papp) were calculated with the following equation: 
Papp= VxdC/AxC0xdT = [cm/sec]; where V = the volume of the solution in the receiving compartment 
(ml), A = the membrane surface area (cell system) or intestinal segment surface area (perfused rat 
intestinal model), C0 = the initial concentration of compound and dC/dt = the change in drug 
concentration in the receiver solution over time. Intestinal segment surface area was calculated 
using the equation for the area of a cylinder (A = 2πrixLi ), where Li is the length of the perfused 
segment of intestine and ri is the internal radius, 0.2 cm [25]. Transport data are expressed as a 
mean of 3 or more determinations ± SEM. 
 
 
Results  
 
Incubation of polyphenolic fraction with simulated gastric juice. 
Although the gastric conditions in vivo are complex with the food matrix affecting the precise pH, the 
incubation of polyphenols at gastric pH can give us information about the stability of polyphenols in 
the gastric environment. An olive oil polyphenolic fraction (1mg/ml) was incubated in water acidified 
with HCl to reacha pH=2 at 37ºC for up to 4h to simulate conditions in the stomach, and the 
products were analyzed by HPLC with photodiode array detection. The results indicate a time 
dependent hydrolysis of conjugated polyphenols as demonstrated by a decline of compounds 
represented by peaks with a retention time (RT) between 40min and 60min, and a corresponding 
progressive increase in peaks representing the hydrolysis products hydroxytyrosol (RT 12,1min) 
and tyrosol (18,3min RT), respectively (figure 1A and 1B). After 30min incubation the amount of 
hydroxytyrosol and tyrosol increased 4.75 and 3.25 times, respectively, and after 4h the amount 
increased 7.41 and 5.15 times, respectively (figure 1C). Interestingly, after 4 hours of hydrolysis, 
some fractions of the conjugated forms are still present unhydrolyzed. This result indicates that the 
amount of hydroxytyrosol and tyrosol that arrive in the small intestine following incubation and 
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passage through the acidic conditions of the stomach may be considerably higher than the amount 
initially present in ingested olive oil. 
 
Transport and metabolism experiments in the perfused rat intestinal model.  
The comparative absorption of HT, TYR, OL and polyphenolic fraction, and the extents to which 
they are conjugated and metabolized during transfer across jejunum and ileum to the serosal side 
was investigated. The transferred compounds were identified and quantified by HPLC with diode 
array detection. Fig 2 illustrates the time course for transfer and metabolism of HT (fig. 2A and B), 
TYR (fig.2C and D), and the polyphenolic extract (POL) (fig.2E and F) in jejunum and ileum 
respectively. Interestingly, oleuropein was not transferred across either small intestinal segments, at 
any time point.  In contrast, hydroxytyrosol (fig. 2A and B) and tyrosol (fig. 2C and D) were rapidly 
absorbed in both jejunum and ileum, following perfusion with the single phenolics, and significant 
amounts of phase I and phase II metabolites were found in the serosal fluid. After HT perfusion, HT, 
3-O-methyl-hydroxytyrosol (homovanillyl alcohol) and the respective glucuronides of both 
compounds were detected following jejunum and ileum passage  (fig. 2A and B). Similarly, after 
perfusion with tyrosol, the parental compound and two new peaks were observed in the serosal 
fluid of both gut segments (fig. 2C and D). Both new peaks disappeared after glucuronidase 
treatment, with a subsequent increase in tyrosol and a new peak, indicating that a glucuronide of 
tyrosol and another glucuronide metabolite were present. This new peak had similar spectral 
properties as tyrosol, but it remains to be identified. Figure 3 indicates that both HT and TYR are 
absorbed in the parental form to a greater extent in the ileum than in the jejunum (fig. 3A and B), 
which may reflect enzymatic profiles in these tissues. The perfusion of the polyphenolic fraction also 
resulted in the transfer of compounds, tyrosol and hydroxytyrosol, and lead to the formation of 
glucuronide conjugates and homovanillyl alcohol (fig. 2E and F and fig. 3C). HPLC chromatograms 
did not reveal the presence of other metabolite resulting from the polyphenolic extract perfusion. 
We calculated the apparent permeability coefficients for hydroxytyrosol and tyrosol in both jejunum 
(Pap[HT]=1.26±0.52x10-5; Papp[TYR]= 3.55±0.11x10-5) and ileum (Papp [HT]=1.41±0.99x10-5; Papp 
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[TYR]=2.91±0.56x10-5) (figure 4), indicating that they are well absorbed in both segments of small 
intestine. 
 
Transport experiments in Caco-2 model. 
Analysis by HPLC of apical (AP) and basolateral (BA) medium over a 2h incubation period with HT 
and TYR demonstrated the enterocyte-mediated absorption and metabolism of the phenolic 
compounds investigated. Figure 5 (panel A) shows a typical HPLC chromatogram obtained after 
analysis of medium from the BA side, following a 2h incubation with HT. It was observed that the HT 
concentration decreases on the AP side, and that the compound can be recovered from the BA 
side, thus demonstrating transfer. HPLC chromatograms also show the presence of two new peaks 
(RT 16.18 and 21.78min), on both, AP and BA side. The peak at 21.78min has been identified by 
RT and spectra comparison with authentic standards as homovanillyl alcohol, the 3-O-methylated 
metabolite of HT. The peak at 16.18min was identified as a glutathionyl conjugate of HT, by 
comparison with a synthesized standard of HT-GSH (see methods) (figure 5B). In comparison to 
experiments with the isolated small intestinal model that demonstrated HT glucuronidation, using 
the caco-2 model the majority of the HT (90%) appeared on the basolateral side as un-metabolized 
HT (figure 3D), and no glucuronidated conjugates were observed. When Caco-2 monolayers were 
incubated with TYR, we observed a decreasing amount of TYR in the AP, and we recovered the 
compound in the BA. In this case we did not detect any new metabolite peaks in the 
chromatograms. In agreement with rat small intestinal studies, when Caco-2 cells where incubated 
with oleuropein, we did not measure any significant decrease of compound on the AP side, and the 
compound was not detected on the BA side at any concentration. 
Following incubation of the monolayer with the polyphenolic fraction, (a mixture containing HT and 
TYR), we measured a decrease in both TYR and HT on the AP side, and both compounds were 
detected on the BA side. No further peaks were detected on the BA side, indicating that other 
compounds present in the polyphenolic mixture were not transferred across the monolayer. 
The rate of absorption (figure 6) and apparent permeability coefficients (Papp) (figure 4) were 
calculated in order to estimate the bioavailability of the compounds. TYR absorption rate was 
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about 60% for all the concentrations loaded, and HT absorption increased with the concentration, 
and was between 35% and 58% (figure 4). The Papp coefficients calculated (2.18±0.37x10-5 and 
5.11±0.59x10-5 cm/sec for HT and TYR respectively) suggest that HT and TYR are well absorbed in 
the small intestine following their oral ingestion. Previous studies have positively correlated Papp 
coefficients obtained on Caco-2 cells, with the absorption in humans, indicating 100% absorption for 
values >1*10-6 [26]. Therefore, we propose that both HT and TYR are very well absorbed in the 
small intestine. 
 
Colonic microflora fermentation: batch culture 
Previous studies have shown that oleuropein is stable in human gastric juice and duodenal fluid 
[20]. Based on the fact that our data demonstrate that oleuropein is not absorbed or metabolized in 
the small intestine, it is likely to reach the large intestine where it will be subject to degradation by 
the colonic microflora. To gain insight into the colonic microflora-mediated biotransformations we 
utilized a anaerobic fermentation system.  Anaerobic suspensions of human colonic micro flora 
were incubated with OL, the supernatants were collected at various time points and analyzed by 
HPLC in order to characterize and to quantify OL and OL-derived microfloral metabolites. A 
representative HPLC chromatogram of the ferment is shown in figure 7 (panel A). The results 
demonstrate that oleuropein was quickly and extensively degraded resulting in the formation of 3 
compounds detected at 11.6min, 36.8min and 53.9min RT (fig.7A).  Based on the RT, the UV 
spectrum, and confirmed by comparisons with an authentic standard, the peak at 11.6min was 
identified as hydroxytyrosol. The two other metabolites remain tp be identified. Figure 7B depicts 
the time-dependent biotransformation of oleuropein by colonic microflora cultures that were 
established from samples obtained from in 3 individual human donors. In agreement with previous 
work on the colonic micro flora-catalyzed degradation of other polyphenols [27], a comparison of 
the different metabolite profiles, as shown in panels B1, B2, and B3 of figure 7, demonstrates that 
the biotransformation of oleuropein was greatly influenced by individual variations in the microbial 
composition, However, although the time course for different donors varies (depending on the 
variation on microflora composition), the micro flora of all donors fully degraded oleuropein 
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resulting in the appearance of 3 new metabolites, one of which being HT. Thus, as previously 
demonstrated for various phenolic acids [28, 29], the micro flora-dependent hydrolysis of oleuropein 
may consequently increase the bioavailability oleuropein-derived HT via the uptake of HT through 
the large intestine. 
 
 
Discussion 
Despite the substantial body of evidence linking the in vitro properties of olive oil polyphenols to the 
health benefits associated with olive oil consumption, there are limited data on absorption and 
metabolism.  In order to obtain more detailed information about their mechanism of action in vivo, it 
is essential to know in which form olive oil polyphenols are when they reach the circulation and 
ultimately the tissues.  Presently, the vast majority of information in the literature is based on 
analysis of blood and urine samples in animal and human studies [12-14, 16, 17, 30-33].  However, 
these studies do not differentiate between the contribution of gastrointestinal metabolism and 
overall absorption and biotransformation of olive oil polyphenols.  We observed significant non-
enzymatic hydrolysis of the conjugated forms olive oil polyphenols under conditions similar to those 
expected during transit through the stomach in vivo.  Although conditions in vivo are more complex 
than in the model used here, with the food matrix affecting the precise pH, it is highly likely that the 
gastric environment achieves a pH of at least 2-3 for a period around 30-minutes, i.e. in order that 
sufficient enzymatic protein degradation may occur (pepsin). Therefore, we suggest that under such 
conditions the stability of complex olive oil polyphenols may be affected and could result in a 
significant increase in the amount of HT and TYR that arrives in the small intestine (4.75 and 3.25 
times respectively after 30min) via the pyloroduodenal junction. In this case, higher amounts of HT 
and TYR may be presented for absorption in the jejunum and ileum than would be expected. 
 
Our absorption studies agree with previous investigations which have shown the presence of HT 
and TYR glucuronides in urine following ingestion of olive oil polyphenols [12, 13, 17, 31, 33]. We 
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detected HT, TYR, homovanillyl alcohol and their glucuronides in the rat small intestine model, 
which agreed with experiments performed in Caco-2 cells, except that no glucuronides were 
detected in the cellular model. This is presumably because Caco-2 cells do not possess UDP-
glucuronosyl transferase activity due to their colonic origin [34].  We stress that caution should be 
used when interpreting absorption and metabolism data from this cell model as it could 
underestimate the true level of absorption of a polyphenol, especially that of the glucuronide 
conjugates.  Similarly, use of the isolated rat small intestine model may not generate other potential 
human metabolites. For example, the results obtained with Caco-2 cells for hydroxytyrosol show 
that the compound is also glutathione conjugated, which is not the case in the rat small intestinal 
segment model.  As mentioned, these differences reflect different characteristics and enzymatic 
profile which exist between Caco-2 cells and small intestine segments, and need to be considered 
when interpreting all polyphenol absorption data.  Indeed the Caco-2 model has been considered a 
suitable model for intestinal CYP3A4 mediated first pass metabolism, but not necessarily for UGT 
mediated glucuronidation [35, 36].  It should also be noted that not all intestinal drug metabolizing 
enzymes are present in this cell line, even though Caco-2 cells have been extensively used in 
studies of uptake and metabolism of flavonoids [21, 37, 38].  
 
Data from the two models give us a more complete understanding of how these compounds are 
absorbed and metabolized in humans.  We have identified for the first time a glutathione conjugate 
of hydroxytyrosol generated in Caco-2 cells. This metabolite may be formed either enzymatically via 
the action of glutathione S-transferase or non-enzymatically via oxidative metabolism of HT followed 
by its reaction with GSH [39].  Conjugations with thiols, such as glutathione, represent a major 
target for quinones, and the detoxification of quinones by GSH is generally considered to be 
cytoprotective. In addition, thiol conjugates of phenolics may be major bioactive forms in vivo and 
may contribute to positive health effects.  We show that the majority of HT and TYR is absorbed, 
and underwent O-methylation (HT), glucuronidation (HT and TYR) and glutathionyl conjugation (HT) 
in the small intestine.  O-methylation and glucuronidation process are common metabolic pathways 
in the small intestine for plant derived phenolic acids [23] and in agreement with previous 
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studies [12, 16, 19] showing the presence of these metabolites in plasma and urine after oral 
administration. Furthermore, in our experiments we did not reveal the presence of homovanillic 
acid, 3-hydroxy-4-methoxy phenylacetic acid, 2-(3,4-dimethoxyphenyl)-ethanol and sulfate-
conjugate metabolites, hydroxytyrosol metabolites found in rat urine [19], so we can presume that 
these metabolites are formed after transport across the small intestine, most probably in the liver. 
 
Oleuropein was not absorbed in the parental form in the small intestine and was not degraded 
under acidic conditions.  Consequently it is likely to reach the large intestine, where it may be 
subjected to rapid degradation by the colonic microflora.  Three major degradation products were 
produced by the microflora, one of them identified as being HT.  Metabolism by colonic bacterial 
species may have the effect of increasing overall HT bioavailability, as released HT can be 
absorbed in the colon, as has been shown for other phenolic acids [28, 29].  In addition, oleuropein 
itself may possess potential prebiotic properties if bacterial groups, such as Bifidobacteria and 
Lactobacillus, may utilize it as a carbon source, but others such as Clostridium and E. coli cannot. 
Due to the rapid rate of oleuropein fermentation in the gut model, future investigations are planned 
to investigate whether oleuropein fermentation by colonic microflora can result in potential ‘prebiotic’ 
changes in microbial composition. 
 
Although metabolic processes in the small intestine may act to decrease the bioavailability and 
consequently the biological effects of native polyphenols, such as hydroxytyrosol and tyrosol, their 
resultant metabolites may be capable of exerting biological effects in vivo: For example Tuck and al. 
[19] reported that the radical scavenging potency of homovanillyl alcohol was similar to 
hydroxytyrosol and that of the 3-O-glucuronide conjugate was more potent when screened in an in 
vitro assay system.  Whilst there has been a major focus on the antioxidant properties, there is an 
emerging evidence that plant derived polyphenols, in particular flavonoids, and their in vivo 
metabolites can also modulate the activity of specific proteins involved in intracellular signaling 
pathways [40]. Many investigations indicate that flavonoids may interact within the mitogen-
activated protein kinase (MAP kinase) signaling pathway [41, 42] and it is possible that through 
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oxidative mechanisms phenolic acids may act in the same way.  As hydroxytyrosol, tyrosol and their 
metabolites are relatively well absorbed in the small intestine compared to flavonoids, future 
investigations will center on their potential cellular actions, as has been shown for other plant 
derived polyphenol metabolites [39, 41, 43-45]. 
 
Our study provides additional information regarding the breakdown of complex olive oil polyphenols 
in the GI tract, in particular the stomach and the large intestine.  We provide novel evidence for the 
breakdown of complex secoirids derivatives of olive oil polyphenols in a physiological time frame in 
the stomach.  This gastric biotransformation effectively increases the relative amount of 
hydroxytyrosol and tyrosol entering the small intestine.  We also identify a new metabolite of 
hydroxytyrosol (glutathione conjugated) and highlight the importance of comparing the transfer and 
metabolism of polyphenols in two different models of the small intestine.  Finally, we show for the 
first time that although oleuropein (a major olive oil polyphenol) is not absorbed in the small 
intestine it is rapidly degraded by the colonic microflora to yield hydroxytyrosol, which may then be 
absorbed. 
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Figure Legends 
 
Figure 1. HPLC chromatogram obtained from a control (panel A) and a sample (panel B) after 2h 
incubation in HCl. Detection was performed at 280nm. Amounts of hydroxytyrosol and tyrosol 
obtained after hydrolytic treatment of olive oil polyphenolic fraction over time (panel C). Data are 
plotted as the mean ± S.E.M. (n=3) and all values are significantly different respect to the control 
(p< 0.001). 
 
Figure 2. Cumulative absorption of olive oil polyphenols and their metabolites over 80min through 
isolated rat jejunum (A, C and E) and ileum (B, D and F) after perfusion with hydroxytyrosol (A, 
B), tyrosol (C, D) and polyphenolic fraction (E, F). Data are plotted as the mean ± S.E.M. of three 
separate experiments. 
 
Figure 3. Relative amount of hydroxytyrosol (A, D), tyrosol (B) and polyphenols (C) and their 
conjugates and metabolites after perfusion through the isolated rat jejunum and ileum (A, B, C) 
and after 2h incubation in Caco-2 cells (D). Data are plotted as the mean ± S.E.M. of three 
separate experiments. 
 
Figure 4. Apparent permeability coefficients (Papp) of hydroxytyrosol and tyrosol in jejunum, 
ileum and Caco-2 monolayers. Data are plotted as the mean ± S.E.M. (n=3) and all values are 
significantly higher than 1*10-6 (p< 0.001). 
 
Figure 5. HPLC chromatogram with photodiode array detection (200-600nm) of the cell culture 
basolateral buffer from Caco-2 monolayers after 2h incubation with HT 100μM (panel A). 
Detection was performed at 280nm. Peaks at 13.09min, 16.18min and 21.78min RT are 
hydroxytyrosol, his glutathionyl-conjugate and homovanillyl alcohol respectively. HPLC 
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chromatogram with photodiode array detection (200-600nm) of the HT-GSH conjugate (panel B) 
obtained after HT incubation in presence of GSH and tyrosinase. 
 
Figure 6. Absorption of hydroxytyrosol and tyrosol in Caco-2 cells after 2h incubation with the 
standard compounds (HT and TYR) and with the polyphenolic fraction (HT-pol and TYR-pol). 
Data are plotted as the mean ± S.E.M. of three separate experiments. 
 
Figure 7. Example HPLC chromatograms with photodiode array detection (200-600nm) 
representing the colonic biotransformation of oleuropein after 8h fermentation (panel A). 
Detection was performed at 280nm. Time-fermentation profiles of oleuropein and its metabolites 
(panel B) in three individual donors (1, 2, 3). 
 
 
 
 
 
 
 
